TTM Announces Proposed Offering of $500 Million of Senior Notes Due 2034

Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy

Percona and Coroot Partner to Bring Full-Stack Observability to Open Source Database Environments

Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1...

SKYX Signs Merger with Leading U.S. AI Smart Home Silicon Valley Backed Company Deako, Aiming to Lead the Smart Home, Builder & Hotel...

Faruqi & Faruqi, LLP Urges Wise Group plc (NASDAQ: WSE) Investors to Seek Counsel Before the September 29, 2026 Lead Plaintiff Deadline...

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

Talogy assessment tool recognized for its contribution to building workplace resilience

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead...

TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for...

Bombardier's Global 8000, the World’s Fastest Civil Aircraft, Received U.K. Civil Aviation Authority (CAA) Approval to Land at London City...

Talogy assessment tool recognized for its contribution to building workplace resilience

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA...

W. P. Carey Provides Business Update on Investment Activity and Tenant Credit

Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival

Delaware Court of Chancery Rules Empery Digital's Board Breached Its Fiduciary Duties

Cloudera and Mistral Partner to Bring Specialized, Sovereign Intelligence to Enterprise Data

Volatus Aerospace Awarded Canadian Defence Contract for Tactical ISR Uncrewed Aircraft Systems for up to 5,000 systems

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference